7,877 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Bought by Vance Wealth Inc.

Vance Wealth Inc. acquired a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 7,877 shares of the pharmacy operator’s stock, valued at approximately $206,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Dark Forest Capital Management LP grew its stake in Walgreens Boots Alliance by 6.5% during the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock worth $654,000 after buying an additional 1,804 shares during the last quarter. Deutsche Bank AG grew its stake in shares of Walgreens Boots Alliance by 36.2% in the third quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator’s stock worth $48,269,000 after purchasing an additional 576,534 shares in the last quarter. Van ECK Associates Corp grew its stake in shares of Walgreens Boots Alliance by 28.2% in the third quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock worth $2,873,000 after purchasing an additional 28,400 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Walgreens Boots Alliance by 3.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,444,686 shares of the pharmacy operator’s stock worth $32,130,000 after purchasing an additional 47,071 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now owns 3,000 shares in the company, valued at $54,150. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now owns 3,000 shares in the company, valued at $54,150. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Valerie B. Jarrett acquired 4,456 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, January 29th. The stock was acquired at an average cost of $22.44 per share, with a total value of $99,992.64. Following the completion of the purchase, the director now owns 4,456 shares in the company, valued at approximately $99,992.64. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 13,456 shares of company stock valued at $270,423. Corporate insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Trading Up 0.6 %

Shares of NASDAQ WBA traded up $0.10 during mid-day trading on Friday, hitting $17.70. 6,592,036 shares of the company traded hands, compared to its average volume of 13,083,050. Walgreens Boots Alliance, Inc. has a 1 year low of $17.49 and a 1 year high of $35.38. The stock has a market capitalization of $15.27 billion, a price-to-earnings ratio of -2.53, a PEG ratio of 1.10 and a beta of 0.73. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The business has a 50 day moving average of $20.01 and a two-hundred day moving average of $21.77.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same period in the prior year, the business posted $1.16 earnings per share. Walgreens Boots Alliance’s revenue was up 6.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 5.65%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio is -14.29%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on WBA. Bank of America decreased their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research note on Tuesday, March 26th. Truist Financial reissued a “hold” rating and issued a $25.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Barclays assumed coverage on Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.